F2R and neoplasm: Although PAR1 is generally considered to promote cancer progression [43] PAR1 may, however, not be the most attractive target to pursue in a cancer setting due to recent observations showing that genetic elimination of PAR1, in fact, aggravates tumor development [36, 44].